HPB & Spleen · 20 October 2025

Tailored Chemotherapy for Gallbladder Cancer: A Better Approach

A prognostic model for gallbladder cancer can refine adjuvant chemotherapy decisions and improve patient outcomes.

In a study of 2,252 patients, age, tumor grade, N stage, tumor size, and sex predicted overall survival more accurately than the TNM system.
The 5-year overall survival rate was only 27.3%.

High-risk patients saw improved survival with adjuvant chemotherapy, while it was detrimental for low-risk and had minimal effect on intermediate-risk groups.

Individualized treatment strategies can optimize outcomes and avoid unnecessary treatments for low-risk patients.

Journal Article by Zheng Y, Zhang D and Lu J in HPB (Oxford)

read the whole article in HPB (Oxford)

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

The latest stitches

Surg Endosc6 Nov 2026

A new cut for robotic liver surgery

A close-to-open cutting method was used for robotic liver resection, with no bile leaks and shorter hospital stays than after laparoscopy.

Surg Endosc6 Nov 2026

Robotic liver resection with short-pitch dividing shortens hospital stay

Robotic liver resection using a close-to-open forceps technique was associated with no bile leakage and a shorter hospital stay than laparoscopic resection, even though more complex resections were performed in the robotic group.

Surg Endosc6 Nov 2026

Robotic bile duct stone surgery: fewer complications

Removing large common bile duct stones with a robot rather than laparoscopically was linked to fewer complications and shorter hospital stays, at a higher cost, in a study from one Chinese hospital.

All papers in HPB & Spleen →